Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD
Public ClinicalTrials.gov record NCT00029614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Psychopharmacology of Adolescents With AUD and ADHD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).
Study identification
- NCT ID
- NCT00029614
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 24 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 13 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Not listed
- Completion
- Jun 30, 2007
- Last update posted
- Apr 27, 2010
2006 – 2007
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Western Psychiatric Institute and Clinic | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Substance Use Disorders trials
Other public records listing Substance Use Disorders. Sorted by last update posted; newest first. Not a recommendation.
- NCT07707115: Interprofessional Simulation Program for Clinical Resilience and Empathy: Project INSPIRE Not yet recruiting
- NCT07210268: Temporal Interference Methods for Addiction Treatment Recruiting
- NCT07232641: Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic Recruiting
- NCT07223398: Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33) Recruiting
- NCT06109571: Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders Active, not recruiting
- NCT06585631: The Collaborative Care PrTNER Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00029614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2010 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00029614 live on ClinicalTrials.gov.